Precision BioSciences receives patent allowances for HBV gene editing program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. MU
2. SPCX
3. APTX:CN
4. SPY
5. IQMX
6. EROC
7. MSTR
8. MSFT
9. SEER
10. NVDA

Go back to Precision BioSciences receives patent allowances for HBV gene editing program
(NASDAQ: DTIL) Delayed: 8.24 +0.06 (0.73%)
Previous Close $8.18    52 Week High $ 
Open $7.95    52 Week Low $ 
Day High $8.53    P/E N/A 
Day Low $7.95    EPS $ 
Volume 424,624